Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Defunct gold mine tailings are natural reservoir for unique bacterial communities revealed by high-throughput sequencing analysis.

Sibanda T, Selvarajan R, Msagati T, Venkatachalam S, Meddows-Taylor S.

Sci Total Environ. 2019 Feb 10;650(Pt 2):2199-2209. doi: 10.1016/j.scitotenv.2018.09.380. Epub 2018 Oct 2.

PMID:
30292113
2.

Some physical and functional properties of finger millet (Eleusine coracana) obtained in sub-Saharan Africa.

Ramashia SE, Gwata ET, Meddows-Taylor S, Anyasi TA, Jideani AIO.

Food Res Int. 2018 Feb;104:110-118. doi: 10.1016/j.foodres.2017.09.065. Epub 2017 Sep 27.

3.

Potential biotechnological capabilities of cultivable mycobiota from carwash effluents.

Sibanda T, Selvarajan R, Tekere M, Nyoni H, Meddows-Taylor S.

Microbiologyopen. 2017 Oct;6(5). doi: 10.1002/mbo3.498. Epub 2017 Jul 17.

4.

Diversity Analysis and Bioresource Characterization of Halophilic Bacteria Isolated from a South African Saltpan.

Selvarajan R, Sibanda T, Tekere M, Nyoni H, Meddows-Taylor S.

Molecules. 2017 Apr 20;22(4). pii: E657. doi: 10.3390/molecules22040657.

5.

Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection.

Tiemessen CT, Shalekoff S, Meddows-Taylor S, Schramm DB, Papathanasopoulos M, Gray G, Sherman G, Coovadia A, Kuhn L.

J Infect Dis. 2010 Nov 1;202(9):1444-53. doi: 10.1086/656535.

6.

Single-dose nevirapine exposure affects T cell response and cytokine levels in HIV type 1-infected women.

Shalekoff S, Meddows-Taylor S, Schramm DB, Gray G, Sherman G, Coovadia A, Kuhn L, Tiemessen CT.

AIDS Res Hum Retroviruses. 2009 Oct;25(10):1049-53. doi: 10.1089/aid.2008.0286. No abstract available.

7.

Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1.

Tiemessen CT, Shalekoff S, Meddows-Taylor S, Schramm DB, Papathanasopoulos MA, Gray GE, Sherman GG, Coovadia AH, Kuhn L.

J Immunol. 2009 May 15;182(10):5914-8. doi: 10.4049/jimmunol.0900419.

8.

Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers.

Shalekoff S, Meddows-Taylor S, Gray GE, Sherman GG, Coovadia AH, Kuhn L, Tiemessen CT.

AIDS. 2009 Apr 27;23(7):789-98. doi: 10.1097/QAD.0b013e328329c784.

9.

Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women.

Shalekoff S, Meddows-Taylor S, Schramm DB, Donninger SL, Gray GE, Sherman GG, Coovadia AH, Kuhn L, Tiemessen CT.

J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):245-54. doi: 10.1097/QAI.0b013e31816fdc77.

10.

African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine.

Kuhn L, Schramm DB, Donninger S, Meddows-Taylor S, Coovadia AH, Sherman GG, Gray GE, Tiemessen CT.

AIDS. 2007 Aug 20;21(13):1753-61.

11.

Development of a whole blood intracellular cytokine staining assay for mapping CD4(+) and CD8(+) T-cell responses across the HIV-1 genome.

Meddows-Taylor S, Shalekoff S, Kuhn L, Gray GE, Tiemessen CT.

J Virol Methods. 2007 Sep;144(1-2):115-21. Epub 2007 May 31.

13.

Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission.

Meddows-Taylor S, Donninger SL, Paximadis M, Schramm DB, Anthony FS, Gray GE, Kuhn L, Tiemessen CT.

J Gen Virol. 2006 Jul;87(Pt 7):2055-65.

14.

Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers.

Van Rie A, Madhi SA, Heera JR, Meddows-Taylor S, Wendelboe AM, Anthony F, Violari A, Tiemessen CT.

Clin Vaccine Immunol. 2006 Feb;13(2):246-52.

16.
17.

CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients.

Sherman GG, Scott LE, Galpin JS, Kuhn L, Tiemessen CT, Simmank K, Meddows-Taylor S, Meyers TM.

Pediatr Res. 2002 Jun;51(6):740-5.

PMID:
12032270
18.

Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero.

Kuhn L, Meddows-Taylor S, Gray G, Tiemessen C.

Clin Infect Dis. 2002 Jan 15;34(2):267-76. Epub 2001 Dec 7. Review.

PMID:
11740717
19.

Interleukin-8 concentrations in the peripheral circulation of human immunodeficiency virus type 1-infected children suggest blunted chemokine responses.

Meddows-Taylor S, Meyers TM, Kuhn L, Tiemessen CT.

Pediatr Infect Dis J. 2001 Aug;20(8):819-20. No abstract available.

PMID:
11734757
20.

Human immunodeficiency virus type 1 envelope-stimulated interleukin-2 production and survival of infected children with severe and mild clinical disease.

Kuhn L, Meyers TM, Meddows-Taylor S, Simmank K, Sherman GG, Tiemessen CT.

J Infect Dis. 2001 Sep 15;184(6):691-8. Epub 2001 Aug 24.

PMID:
11517429
21.
22.

Antituberculosis treatment: increasing evidence for drug effects on innate cellular immunity.

Tiemessen CT, Shalekoff S, Meddows-Taylor S, Martin DJ.

Clin Diagn Lab Immunol. 2001 Jul;8(4):686-9. Review. No abstract available.

23.

Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission.

Kuhn L, Meddows-Taylor S, Gray G, Trabattoni D, Clerici M, Shearer GM, Tiemessen C.

Clin Exp Immunol. 2001 Mar;123(3):443-50.

26.

T-helper cell responses among HIV-infected children in Soweto, South Africa.

Meyers TM, Kuhn L, Meddows-Taylor S, Simmank K, Sherman GG, Tiemessen CT.

Ann N Y Acad Sci. 2000 Nov;918:373-6. No abstract available.

PMID:
11131729
27.
28.

Supplemental Content

Loading ...
Support Center